Metraipolis › archive › dc_2a5316f1990e
D2ML: Models for Direct-to-Biology Small Molecule Screening — arXiv:2610.41070
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2610.41070
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-03T08:12:49.817Z
- SHA-256 of the archived text
a67046cfcb480f77deaf6e73e5496d8f4f011705f2efab882020518131a44889- Stable URL of this page
https://metraipolis.com/documento/dc_2a5316f1990e
How to cite
D2ML: Models for Direct-to-Biology Small Molecule Screening — arXiv:2610.41070 — arXiv (en), https://arxiv.org/abs/2610.41070 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2a5316f1990e (Metraipolis archive dc_2a5316f1990e, sha256 a67046cfcb480f77deaf6e73e5496d8f4f011705f2efab882020518131a44889)
BibTeX
@misc{dc2a5316f1990e,
title = {D2ML: Models for Direct-to-Biology Small Molecule Screening — arXiv:2610.41070},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2610.41070},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2a5316f1990e; sha256 a67046cfcb480f77deaf6e73e5496d8f4f011705f2efab882020518131a44889},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.41070. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Direct-to-biology (D2B) screening enables rapid testing of newly synthesized molecules without purification. However, uncertain concentrations in crude mixtures and limited purified-compound measurements complicate the use of these data in machine learning. Here we show that models tailored to the structure of D2B data can improve prediction and guide the discovery of more potent and selective compounds. Our assay-aware models predict activity from single-point screens, relative potency across targets from crude dose-response assays, and absolute potency from purified-compound measurements. For crude assays, potency ratios between targets tested from the same well can retain selectivity information despite uncertain concentrations. A joint model that shares information across stages and balances their contributions to training improved predictions over separate neural networks. The largest gain was in crude dose-response selectivity prediction, where rank correlation increased from 0.27 to 0.40. In a separate experiment, independently trained models guided the selection of 84 new compounds to improve ROS1 potency while limiting activity against the anti-target TRKB. Synthesis and testing identified compounds that extended the measured Pareto front, achieving better combinations of potency and selectivity than those in the training data. The most selective new compound achieved a ROS1 IC50 of 14.7 nM and 233-fold selectivity over TRKB. By comparison, the most selective training compound had a ROS1 IC50 of 20.3 nM and 79-fold selectivity. ATLAS provides the experimental setting for this approach, supporting synthesis and screening of 1,000-10,000 model-selected compounds in two- to three-week cycles. Together, these results show how assay-aware learning can use the full D2B assay sequence to guide multi-objective molecular optimization. Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.LG, nuovi lavori del giorno). Categorie arXiv: Biomolecules (q-bio.BM) ; Machine Learning (cs.LG). Pagina del lavoro: https://arxiv.org/abs/2610.41070 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-11-03T08:02:38.975Z dalla pagina https://arxiv.org/list/cs.LG/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).